Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07537244Not ApplicableActive Not Recruiting

Impact of GEA Simultaneous to VSG on Post-operative GERD

Role: lead

NCT03692455Enrolling By Invitation

Effect of Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass on Gastroesophageal Reflux Disease: An 8-Year Prospective Cohort Study

Role: lead

NCT00951093Completed

Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass

Role: lead

NCT01212835Not ApplicableTerminated

Effect of RING on Gastroesophageal Reflux (GERD) After RYGBP

Role: lead

All 4 trials loaded